Nursing facility
Eladh, LP
Eladh, LP was paid $5.38M by Medicaid between Jan 2018 and Dec 2024, across 132 billing codes. Its largest line is 0450, Emergency room services — 22% of everything it billed.
33Billing provider infoELADH, LP
LOS ANGELES, CA 90023
LOS ANGELES, CA 90023
33aNPI1417957473assigned 07/29/2005
33bProvider typeSkilled Nursing Facility
28Total paid$5.38M
24GClaims253,248
24DCodes billed132
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Skilled Nursing Facility providers in California
Rank by total paid#18 of 547
Median peer was paid$73K
This provider vs. median74×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 46,349 | $893K | |
| 2019 | 44,915 | $1.06M | |
| 2020 | 29,434 | $601K | |
| 2021 | 23,519 | $494K | |
| 2022 | 31,546 | $771K | |
| 2023 | 40,413 | $830K | |
| 2024incomplete | 37,072 | $737K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 22% | 29,464 | 27,109 | $1.19M |
| 70450 | Computed tomography, head or brain; without contrast material | 5.8% | 3,217 | 3,044 | $314K |
| Z7502 | 5.8% | 8,382 | 8,162 | $311K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.2% | 5,689 | 5,398 | $278K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4.4% | 2,328 | 2,217 | $236K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.4% | 6,542 | 5,927 | $235K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.0% | 3,508 | 3,163 | $162K |
| 80053 | Comprehensive metabolic panel | 2.6% | 15,670 | 14,679 | $139K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.6% | 7,325 | 6,980 | $138K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.5% | 4,302 | 4,091 | $132K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.2% | 2,091 | 2,000 | $118K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.0% | 1,524 | 1,449 | $109K |
120 more codes
| 99199 | Unlisted special service, procedure or report | 1.9% | 2,570 | $101K |
| 0206 | 1.9% | 25 | $101K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.8% | 3,516 | $98K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.8% | 4,126 | $95K |
| 99285 | Emergency room visit (most serious) | 1.7% | 628 | $93K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 15,676 | $91K |
| 71045 | Radiologic examination, chest; single view | 1.6% | 6,586 | $84K |
| 99283 | Emergency room visit (moderate) | 1.4% | 1,417 | $76K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1.3% | 1,258 | $70K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.2% | 2,131 | $66K |
| 0360 | 1.2% | 1,112 | $66K | |
| 94642 | 1.1% | 650 | $58K | |
| J3490 | Unclassified drugs | 1.0% | 8,425 | $54K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,088 | $46K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 434 | $44K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 843 | $38K |
| Z7610 | <1% | 2,912 | $38K | |
| 0270 | <1% | 4,367 | $36K | |
| 83880 | <1% | 1,818 | $34K | |
| 84484 | <1% | 4,380 | $32K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 969 | $31K |
| 0720 | <1% | 843 | $31K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,771 | $31K |
| 0250 | <1% | 7,480 | $30K | |
| 0272 | <1% | 2,573 | $28K | |
| 83690 | <1% | 5,287 | $27K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,548 | $26K |
| 0636 | <1% | 2,794 | $26K | |
| 59025 | Fetal non-stress test | <1% | 1,613 | $26K |
| 0710 | <1% | 1,680 | $25K | |
| 84703 | <1% | 4,792 | $24K | |
| 83605 | <1% | 2,499 | $23K | |
| 81001 | <1% | 9,334 | $23K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 356 | $23K |
| 87040 | <1% | 1,763 | $23K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 4,327 | $21K |
| 85730 | <1% | 4,100 | $17K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 613 | $17K |
| 0510 | <1% | 647 | $17K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 379 | $16K |
| 85610 | <1% | 4,426 | $14K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,872 | $14K |
| 0750 | <1% | 83 | $13K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,949 | $13K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 331 | $10K |
| 96368 | <1% | 414 | $8K | |
| Z7514 | <1% | 128 | $7K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,625 | $7K |
| 82948 | <1% | 2,283 | $7K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,127 | $7K |
| 87807 | <1% | 1,222 | $7K | |
| 76801 | <1% | 158 | $7K | |
| 87186 | <1% | 997 | $6K | |
| 80320 | <1% | 2,438 | $6K | |
| 82140 | <1% | 624 | $6K | |
| 85027 | <1% | 1,353 | $6K | |
| 87077 | <1% | 1,048 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 861 | $5K |
| 90715 | <1% | 134 | $5K | |
| 84702 | <1% | 316 | $4K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 70 | $4K |
| 86769 | <1% | 140 | $4K | |
| 87430 | <1% | 546 | $3K | |
| 0160 | <1% | 87 | $3K | |
| 85007 | <1% | 1,372 | $3K | |
| 88312 | <1% | 323 | $3K | |
| 0300 | <1% | 783 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 180 | $2K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 270 | $2K |
| J2704 | Injection, propofol, 10 mg | <1% | 785 | $2K |
| V2632 | Posterior chamber intraocular lens | <1% | 12 | $2K |
| 86328 | <1% | 65 | $2K | |
| 72131 | <1% | 25 | $2K | |
| 86901 | <1% | 933 | $2K | |
| 81003 | <1% | 1,188 | $2K | |
| 73562 | <1% | 101 | $2K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 39 | $2K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 27 | $2K |
| 87071 | <1% | 460 | $1K | |
| 73630 | <1% | 72 | $1K | |
| 86900 | <1% | 589 | $1K | |
| 86850 | <1% | 403 | $1K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 211 | $1K |
| 70486 | <1% | 13 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,510 | $964.49 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 112 | $912.90 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 235 | $809.79 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 12 | $767.40 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 28 | $676.02 |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 94 | $668.33 |
| 87400 | <1% | 194 | $659.02 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 44 | $655.86 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 203 | $640.98 |
| 73610 | <1% | 38 | $620.30 | |
| A4649 | Surgical supply; miscellaneous | <1% | 608 | $582.28 |
| 71010 | <1% | 34 | $506.26 | |
| 85379 | <1% | 84 | $485.73 | |
| 82009 | <1% | 116 | $466.05 | |
| 0258 | <1% | 113 | $384.52 | |
| 0324 | <1% | 55 | $341.09 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 83 | $294.96 |
| 80329 | <1% | 73 | $291.70 | |
| 80354 | <1% | 361 | $262.68 | |
| 73130 | <1% | 16 | $262.28 | |
| J1815 | Injection, insulin, per 5 units | <1% | 55 | $245.60 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 50 | $216.97 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 78 | $199.91 |
| A6451 | Moderate compression bandage, elastic, knitted/woven, load resistance of 1.25 to 1.34 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard | <1% | 36 | $191.45 |
| 73110 | <1% | 13 | $163.35 | |
| 74018 | <1% | 12 | $158.47 | |
| 0370 | <1% | 84 | $146.17 | |
| 87420 | <1% | 34 | $143.67 | |
| 83735 | <1% | 28 | $95.96 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 13 | $87.65 |
| 84512 | <1% | 14 | $75.76 | |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 13 | $45.47 |
| 81025 | <1% | 23 | $42.18 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 12 | $18.80 |
| A6402 | Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 72 | $4.43 |
| 0301 | 0% | 243 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMACPHERSON, JAMES (MANAGER)
| Provider | Location | Paid |
|---|---|---|
| CHHP Holdings II, LLC | Huntington Park, CA | $17.21M |
| Gardena Hospital LP | Gardena, CA | $15.36M |
| CPH Hospital Management LLC | Norwalk, CA | $3.68M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.